Literature DB >> 28156189

Feline glioma: a retrospective study and review of the literature.

Daniel R Rissi1, Andrew D Miller2.   

Abstract

Case series summary This study aimed to evaluate the pathologic and diagnostic features of 13 cases of feline glioma diagnosed at two veterinary diagnostic institutions over 16 years. A retrospective search was conducted using the laboratory information system. Selected cases were reviewed, tumors were classified according to the 2007 World Health Organization Classification of Tumours of the Central Nervous System, and tissue sections were submitted to an immunohistochemistry panel for further characterization. Affected cats were adults (average age 8 years), and male neutered (9/13) domestic shorthair cats (12/13) were over-represented. Clinical signs had acute onset and were progressive, lasting from 1-60 days (average course 20.7 days). Euthanasia was elected in all but one case, owing to a poor prognosis or because of a suspicion of rabies. Tumors occurred in the telencephalon (8/13), spinal cord (3/13) and brainstem (2/13). Gross changes in seven cases consisted of well- or poorly demarcated, gray-to-brown, soft, gelatinous masses that often caused secondary changes to the brain. The final diagnosis and classification were made based on histopathology and immunohistochemistry. Diagnoses consisted of oligodendroglioma (six cases), anaplastic astrocytoma (two cases), oligoastrocytoma, anaplastic ependymoma, gliomatosis cerebri, glioblastoma and anaplastic oligodendroglioma (one case each). Relevance and novel information This article confirms the need for a full neurologic and neuropathologic examination in cats with clinical neurologic disease. In addition, it highlights and proposes a complete routine immunohistochemical panel for diagnostic confirmation and differentiation between glioma and other morphologically similar central nervous system neoplasms in cats.

Entities:  

Mesh:

Year:  2017        PMID: 28156189     DOI: 10.1177/1098612X16689506

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  9 in total

1.  Angiocentric astrocytoma in a cat.

Authors:  Daniel R Rissi; Brittany J McHale; Anibal G Armién
Journal:  J Vet Diagn Invest       Date:  2019-04-25       Impact factor: 1.279

2.  OLIG2 immunolabeling in feline ependymoma.

Authors:  Elena A Demeter; Marc Kent; Eric N Glass; Daniel R Rissi; John Edwards; Andrew D Miller
Journal:  J Vet Diagn Invest       Date:  2022-06-27       Impact factor: 1.569

3.  Doublecortin immunolabeling and lack of neuronal nuclear protein immunolabeling in feline gliomas.

Authors:  Jessica A Elbert; Daniel R Rissi
Journal:  J Vet Diagn Invest       Date:  2022-06-09       Impact factor: 1.569

4.  Primary nervous system lymphoma in cats.

Authors:  Daniel R Rissi; Brittany J McHale; Andrew D Miller
Journal:  J Vet Diagn Invest       Date:  2022-04-20       Impact factor: 1.569

5.  Diagnosis and clinical outcome following surgical resection of an intracranial grade III anaplastic gemistocytic astrocytoma in a cat.

Authors:  Vishal D Murthy; Molly L Liepnieks; Melissa A Roy; Kevin D Woolard; Beverly K Sturges; Chai-Fei Li
Journal:  JFMS Open Rep       Date:  2020-07-27

6.  Cerebral gliosarcoma with perivascular involvement in a cat.

Authors:  Patricia Álvarez; Annette Wessmann; Mireia Pascual; Oriol Comas; Dolors Pi; Martí Pumarola
Journal:  JFMS Open Rep       Date:  2019-10-10

7.  Case Report: Primary Diffuse Leptomeningeal Oligodendrogliomatosis in a Young Adult Cat.

Authors:  Elisa Chludzinski; Christina Puff; Jürgen Weber; Marion Hewicker-Trautwein
Journal:  Front Vet Sci       Date:  2021-12-15

8.  Malignant oligoastrocytoma in the spinal cord of a cat.

Authors:  Dai Hasegawa; Keisuke Aoshima; Kazuyoshi Sasaoka; Atsushi Kobayashi; Mitsuyoshi Takiguchi; Takashi Kimura
Journal:  J Vet Med Sci       Date:  2022-07-29       Impact factor: 1.105

9.  Invasive nasal histiocytic sarcoma as a cause of temporal lobe epilepsy in a cat.

Authors:  Koen M Santifort; Ben Jurgens; Guy Cm Grinwis; Ingrid Gielen; Björn P Meij; Paul Jj Mandigers
Journal:  JFMS Open Rep       Date:  2018-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.